Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | C5AR1 | P21730 | 10/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.31 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17169600 | 0.87 | ALDH1A1 (0.34) | ALDH1A1ALOX15TSHRC5AR1POLB | |
| SCHEMBL17169594 | 0.82 | C5AR1 (0.30) | C5AR1 | |
| SCHEMBL17169568 | 0.80 | CYP17A1 (0.34) | ALDH1A1ALOX15TSHRPOLBHTT | |
| SCHEMBL17169593 | 0.80 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHRC5AR1FAAH | |
| SCHEMBL17169591 | 0.80 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHRC5AR1FAAH | |
| SCHEMBL24631896 | 0.80 | ALDH1A1 (0.40) | ALDH1A1ALOX15TSHRC5AR1FAAH | |
| SCHEMBL17173375 | 0.78 | ALDH1A1 (0.39) | ALDH1A1ALOX15TSHRC5AR1FAAH | |
| SCHEMBL17169583 | 0.78 | TSHR (0.37) | ALDH1A1ALOX15TSHRFAAHDPP4 | |
| SCHEMBL17169637 | 0.76 | SLC6A2 (0.34) | ALDH1A1ALOX15TSHRFAAHMGLL | |
| SCHEMBL17169602 | 0.76 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHRC5AR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9911928-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
| US-9911928-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
| US-9905785-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-02-27 | — | — | US | disclosed |
| US-9905785-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-02-27 | — | — | US | disclosed |
| US-20160276603-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2016-09-22 | — | — | US | disclosed |
| US-20160276603-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2016-09-22 | — | — | US | disclosed |
| US-20150295189-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-10-15 | — | — | US | disclosed |
| US-20150295189-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160276603-A1 | Organic Electroluminescent Materials and Devices | EML4, BICRA, TBCB | ALDH1A1 889/4885ALOX15 4280/4885TSHR 3389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.